Description

A targeted panel to evaluate autoimmune and inflammatory complications after COVID-19.

Overview:

Many individuals experience new or worsening joint pain, muscle aches, fatigue, or autoimmune-like symptoms following COVID-19 infection. Post-viral autoimmune activation is increasingly recognized as a complication of both acute COVID-19 and long COVID.

This Post-COVID Rheumatologic Panel includes blood tests that evaluate immune system activation, inflammation, and the presence of autoantibodies. It’s designed to help uncover signs of autoimmune disease, inflammatory arthritis, or muscle inflammation that may emerge following infection.

What This Panel Measures:

CK, Total (Creatine Kinase)

  • Why it matters: CK is an enzyme found in muscle tissue. Elevated levels may indicate muscle inflammation (myositis), damage, or autoimmune muscle disorders — symptoms often reported in post-COVID patients.
  • Post-COVID relevance: Helps assess unexplained muscle pain, weakness, or fatigue.

Rheumatoid Factor (Quantitative)

  • Why it matters: Rheumatoid factor (RF) is an autoantibody commonly elevated in rheumatoid arthritis and other autoimmune disorders.
  • Post-COVID relevance: Helps detect signs of post-viral inflammatory arthritis, which can mimic or trigger RA-like symptoms.

ANA (Anti-Nuclear Antibodies)

  • Why it matters: ANA is a general screening test for autoimmunity. A positive result may indicate the presence of autoimmune diseases such as lupus, Sjögren’s syndrome, or mixed connective tissue disease.
  • Post-COVID relevance: Many post-COVID patients develop transient or persistent positive ANA, which may contribute to fatigue, rash, joint pain, and more.

Anti-Cardiolipin Antibodies (IgG, IgM, IgA)

  • Why they matter: These antibodies are part of the antiphospholipid syndrome (APS) panel, which is associated with abnormal clotting, miscarriage, and autoimmune risk.
  • IgG & IgM: Most common for diagnosing APS.
  • IgA: Useful in identifying seronegative patients.
  • Post-COVID relevance: COVID-19 is known to increase clotting risk, and these antibodies may persist or emerge post-infection, leading to complications like blood clots or vascular inflammation.

CCP IgG (Cyclic Citrullinated Peptide Antibodies)

  • Why it matters: A highly specific marker for rheumatoid arthritis. Anti-CCP antibodies often appear before symptoms and are used to confirm RA diagnosis in patients with joint pain or positive RF.
  • Post-COVID relevance: Some patients may develop new-onset inflammatory arthritis resembling RA, and this test helps distinguish it.

Why This Panel Matters After COVID-19:

COVID-19 can trigger immune dysregulation, leading to:

  • Inflammatory arthritis
  • Muscle inflammation (myositis)
  • Autoimmune syndromes (e.g., lupus-like symptoms)
  • Blood clot risk due to immune system activation

This panel helps identify underlying causes of symptoms like:

  • Joint pain or swelling
  • Muscle aches and fatigue
  • Skin rashes
  • Numbness or tingling
  • Abnormal clotting or bruising

Test Details:

  • Sample Type: Blood
  • Fasting: Not required